These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


319 related items for PubMed ID: 372482

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Serological properties and immunobiological activities of lipopolysaccharides from black-pigmented and related oral Bacteroides species.
    Fujiwara T, Nishihara T, Koga T, Hamada S.
    J Gen Microbiol; 1988 Nov; 134(11):2867-76. PubMed ID: 3151207
    [Abstract] [Full Text] [Related]

  • 25. Cellular mechanism of endotoxin unresponsiveness in C3H/HeJ mice.
    Glode LM, Scher I, Osborne B, Rosenstreich DL.
    J Immunol; 1976 Feb; 116(2):454-61. PubMed ID: 129492
    [Abstract] [Full Text] [Related]

  • 26. B-cell activation by lipopolysaccharide. Distinct pathways for induction of mitosis and antibody production.
    Hoffmann MK, Galanos C, Koenig S, Oettgen HF.
    J Exp Med; 1977 Dec 01; 146(6):1640-7. PubMed ID: 303685
    [Abstract] [Full Text] [Related]

  • 27. In vitro proliferative response and polyclonal antibody production in spleen cells of immunologically defective CBA/N and C3H/HeJ mice by water-soluble adjuvant (Bu-WSA) extracted from Bacterionema matruchotii.
    Okumura S, Nitta T, Nakano M.
    Microbiol Immunol; 1981 Dec 01; 25(11):1139-49. PubMed ID: 7035843
    [Abstract] [Full Text] [Related]

  • 28. Synergy between T cell-replacing factor and bacterial lipopolysaccharides (LPS) in the primary antibody response in vitro: a model for lipopolysaccharide adjuvant action.
    Jacobs DM.
    J Immunol; 1979 Apr 01; 122(4):1421-6. PubMed ID: 376717
    [Abstract] [Full Text] [Related]

  • 29. Characterization of a congenitally LPS-resistant, athymic mouse strain.
    Vogel SN, Hansen CT, Rosenstreich DL.
    J Immunol; 1979 Feb 01; 122(2):619-22. PubMed ID: 368244
    [Abstract] [Full Text] [Related]

  • 30. Adjuvant actions of linear mannan-possessing lipopolysaccharide (LPS) in LPS-resistant C3H/HeJ mice.
    Ohta M, Kido N, Nakashima I, Kato N.
    Immunology; 1985 Nov 01; 56(3):571-3. PubMed ID: 2416680
    [Abstract] [Full Text] [Related]

  • 31. Modulation of immune response by bacterial lipopolysaccharide (LPS): multifocal effects of LPS-induced suppression of the primary antibody response to a T-dependent antigen.
    Uchiyama T, Jacobs DM.
    J Immunol; 1978 Dec 01; 121(6):2340-6. PubMed ID: 363944
    [Abstract] [Full Text] [Related]

  • 32. Lipopolysaccharide from Brucella abortus behaves as a T-cell-independent type 1 carrier in murine antigen-specific antibody responses.
    Betts M, Beining P, Brunswick M, Inman J, Angus RD, Hoffman T, Golding B.
    Infect Immun; 1993 May 01; 61(5):1722-9. PubMed ID: 8478060
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Structural and genetic basis of the in vivo immune response to TNP-LPS.
    Jacobs DM.
    J Immunol; 1975 Oct 01; 115(4):988-92. PubMed ID: 1100725
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.